Skip to main content

Startup developing diagnostic test for colon cancer raises $105M

The startup's fresh financing comes as it is completing a clinical trial for its diagnostic test designed to detect colon cancer.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.